Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 5Gastrointestinal 1Breast 1

Conditions

Pancreatic Neoplasms 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Teratoma 1Sarcoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Fatigue 1Colorectal Subepithelial Lesions 1Central Nervous System Neoplasms 1Brain Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 35Nivolumab 13Cyclophosphamide 11fludarabine 9aldesleukin 9atezolizumab 7Magnetic Resonance Spectroscopy 7Carboplatin 7Specimen Handling 6Ipilimumab 6Early Intervention, Educational 6Cisplatin 6Trastuzumab 5Paclitaxel 5Methods 5Biopsy 5Bevacizumab 5durvalumab 4Vaccines 4Surveys and Questionnaires 4Radiotherapy 4Papillomavirus Vaccines 4Interleukin-2 4Docetaxel 4tisotumab vedotin 3spartalizumab 3fludarabine phosphate 3cemiplimab 3aflibercept 3Tomography, X-Ray Computed 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Restraint, Physical × Gastrointestinal × Clear all
NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

University of Chicago

Recruiting
20 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡